Prime Medicine, Inc. (PRME)
3.61
-0.38
(-9.52%)
USD |
NASDAQ |
Oct 12, 13:01
Prime Medicine Net Income (TTM) : -187.89M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -187.89M |
| March 31, 2026 | -198.37M |
| December 31, 2025 | -201.14M |
| September 30, 2025 | -197.34M |
| June 30, 2025 | -199.28M |
| March 31, 2025 | -202.01M |
| December 31, 2024 | -195.88M |
| September 30, 2024 | -219.25M |
| June 30, 2024 | -217.44M |
| March 31, 2024 | -204.50M |
| Date | Value |
|---|---|
| December 31, 2023 | -198.13M |
| September 30, 2023 | -171.77M |
| June 30, 2023 | -150.42M |
| March 31, 2023 | -137.38M |
| December 31, 2022 | -121.82M |
| September 30, 2022 | -145.45M |
| June 30, 2022 | -132.51M |
| March 31, 2022 | -102.55M |
| December 31, 2021 | -165.37M |
| September 30, 2021 | -105.02M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Beam Therapeutics, Inc. | -85.43M |
| Twist Bioscience Corp. | -136.72M |
| Intellia Therapeutics, Inc. | -399.98M |
| Moderna, Inc. | -3.151B |
| Q32 Bio, Inc. | 33.79M |